Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
283 Leser
Artikel bewerten:
(1)

Smartee Denti-Technology: Smartee Strengthens Clinical Engagement in the DACH Region with First GS Summit in Cologne and Presence at TPAO Congress

COLOGNE, Germany, Dec. 12, 2025 /PRNewswire/ -- Smartee Denti-Technology hosted its first GS-focused clinical summit in Cologne on November 27, deepening its collaboration with orthodontists across the DACH region. Although Smartee has operated in Germany for more than 2 years through its local subsidiary, the Cologne meeting marks the company's first European event dedicated specifically to GS mandibular repositioning technology. The following day, Smartee participated in the TPAO Congress, where Chief Scientist Prof. Gang Shen delivered an invited keynote lecture on GS technology-highlighting the growing academic and clinical interest surrounding Smartee's functional orthodontic innovations.

Prof. Gang Shen delivered an invited keynote lecture at the TPAO Congress

Cologne Summit: A Practical, Clinician-Led Exchange on GS Technology

The inaugural Smartee DACH GS Summit gathered orthodontists from Germany and neighboring countries for a full day of focused discussion on "Redefining Adult Mandibular Repositioning with Aligner Therapy."

Key moments included:

  • Prof. Dr. Gang Shen, Chief Scientist for Smartee GS Technology, and Chief Orthodontist, Taikang Bybo Dental, delivers two in-depth sessions on the biological mechanisms behind Mandibular Advancement Repositioning Technology (MART) and clinical management protocols for the S8-SGTB system.
  • Mr. Matthias Peper, the President of TPAO Congress, shares his first clinical experiences with Smartee's GS mandibular repositioning system, including case selection, planning workflows, and early treatment results.
  • Dr. Werner Schupp, Editor-in-Chief of the Journal of Aligner Orthodontics, demonstrates how integrating individualized jaw-movement data into digital planning can improve functional predictability from the onset of treatment.
Dr. Werner Schupp (left) and Mr. Matthias Peper (right) are presenting clear aligner clinical experience

The summit concluded with Prof. Shen's review of complex adult GS cases, followed by the awarding of the Smartee GS Course Certificate to participating clinicians.

TPAO Congress: Elevating the Dialogue on Functional Orthodontics

At the 4th TPAO Congress (November 28-29), Smartee engaged with more than 1,300 orthodontists and dental technicians at one of Europe's most influential platforms for aligner-based treatment planning and interdisciplinary learning.

Smartee's booth showcased the company's comprehensive clear aligner portfolio for children and adults, including its five product series and newly introduced packaging supported by a Disney-licensed Iron Man design-an eye-catching highlight among attendees.

Adding scientific depth to Smartee's presence, Prof. Gang Shen delivered a keynote lecture titled: "Mandibular Repositioning Therapy GS: Fundamental Mechanisms, Therapeutic Procedures, and Clinical Efficacy."

His talk outlined why GS therapy offers a predictable and biologically grounded solution for adult mandibular repositioning-reinforcing its relevance within the broader European orthodontic community.

Deepening Long-Term Presence in the European Market

The Cologne GS Summit and involvement at TPAO reflect Smartee's continued commitment to the European orthodontic landscape. Rather than an introduction to the market, these events signal a strengthening of the company's long-standing presence and a growing interest in GS-based functional orthodontics.

With sustained investment in digital innovation, clinician training, and international academic exchange, Smartee is poised to further expand the clinical influence of GS technology in Europe and beyond.

Photo - https://mma.prnewswire.com/media/2843508/Prof_Gang_Shen_delivered_invited_keynote_lecture_TPAO_Congress.jpg
Photo - https://mma.prnewswire.com/media/2843509/Dr_Werner_Schupp__left__Mr_Matthias_Peper__right__presenting_clear.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/smartee-strengthens-clinical-engagement-in-the-dach-region-with-first-gs-summit-in-cologne-and-presence-at-tpao-congress-302640066.html

© 2025 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.